TAK Projected Dividend Yield
ADR (Sponsored)/Takeda Pharmaceutical Co Ltd ( NYSE : TAK )Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. Co. has a geographically diversified global business and provides its prescription drugs in Japan and overseas. Co.'s principal pharmaceuticals are antidiabetic, antihypertensive medicine, drugs for multiple myeloma and mantle cell lymphoma, medicine for reflux esophagitis, and hyperuricemia treatment. Co. focuses its R&D activities on four core therapeutic areas of oncology, rare genetics and hemotology, neuroscience, gastroenterology, plasma-derived therapies and vaccines. 24 YEAR PERFORMANCE RESULTS |
TAK Dividend History Detail TAK Dividend News TAK Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
N/A |
Mar 28, 2024 |
Jul 08, 2024 |
0.2922 |
2024 Total: |
0.2922 |
||||
2023 |
N/A |
N/A |
Sep 29, 2023 |
Dec 11, 2023 |
0.3191 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jul 10, 2023 |
0.3100 |
2023 Total: |
0.6290 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 12, 2022 |
0.3296 |
2022 |
N/A |
N/A |
Mar 31, 2022 |
Jul 11, 2022 |
0.3301 |
2022 Total: |
0.6596 |
||||
2021 |
N/A |
N/A |
Sep 30, 2021 |
Dec 13, 2021 |
0.3969 |
2021 |
N/A |
N/A |
Mar 31, 2021 |
Jul 12, 2021 |
0.4066 |
2021 Total: |
0.8035 |
||||
2020 |
N/A |
N/A |
Sep 30, 2020 |
Dec 11, 2020 |
0.4305 |
2020 |
N/A |
N/A |
Mar 31, 2020 |
Jul 06, 2020 |
0.4191 |
2020 Total: |
0.8496 |
||||
2019 |
N/A |
N/A |
Sep 30, 2019 |
Dec 12, 2019 |
0.4111 |
2019 |
N/A |
N/A |
Mar 29, 2019 |
Jul 10, 2019 |
0.4172 |
2019 Total: |
0.8283 |